Micardis HCT 80-25 MG tablet UD 30S
Ended Awarded
- Contract number
- SPE2DB25FJZ41
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,358
Award facts
- Contract value 100% obligated
- $3,357.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Micardis HCT 80-25 mg tablets in unit dose packaging (30-count) with a ceiling value of $3,357.60. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures. The place of performance is AmerisourceBergen's corporate facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 18, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, maintains an extensive portfolio of federal contracts supplying brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Micardis HCT is an antihypertensive medication combining telmisartan and hydrochlorothiazide, commonly used in military and veteran healthcare systems for blood pressure management. The company's federal contract awards demonstrate consistent capability to fulfill medical supply needs through open competition, with delivery orders ranging from modest to substantial values under firm fixed-price arrangements.
Quick answers
Who was awarded contract SPE2DB25FJZ41?
SPE2DB25FJZ41 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 17, 2025.
How much is contract SPE2DB25FJZ41 worth?
The government has obligated $3,358 on SPE2DB25FJZ41.
Is contract SPE2DB25FJZ41 an order under another contract?
Yes. SPE2DB25FJZ41 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJZ41 competed?
The extent of competition for SPE2DB25FJZ41 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award